Particularly in PCa, ELOVL2 demonstrates a unique tumor-suppressive function, where its high expression is associated with favorable clinical outcomes, while its knockdown enhances malignant phenotypes including proliferation, migration, and invasion in PCa cells (Hu et al., 2022). The gene discussed is ELOVL2; the disease is posterior cortical atrophy.